Spliceosome mutations (SF3B1, SRSF2, and U2AF1) were enriched in individuals with thrombocytopenia compared with their matched controls (3.4% vs 1.1%; P = 0.007; Figure 3A). This evidence concerns the gene SF3B1 and Thrombocytopenia.